SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-100745
Filing Date
2021-08-05
Accepted
2021-08-05 16:07:16
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cldx-20210630x10q.htm   iXBRL 10-Q 1322749
2 EX-31.1 cldx-20210630xex31d1.htm EX-31.1 13551
3 EX-31.2 cldx-20210630xex31d2.htm EX-31.2 13654
4 EX-32.1 cldx-20210630xex32d1.htm EX-32.1 8332
  Complete submission text file 0001104659-21-100745.txt   5817278

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cldx-20210630.xsd EX-101.SCH 28982
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cldx-20210630_cal.xml EX-101.CAL 45489
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cldx-20210630_def.xml EX-101.DEF 115437
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cldx-20210630_lab.xml EX-101.LAB 348384
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cldx-20210630_pre.xml EX-101.PRE 250152
10 EXTRACTED XBRL INSTANCE DOCUMENT cldx-20210630x10q_htm.xml XML 1231324
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 211148163
SIC: 2835 In Vitro & In Vivo Diagnostic Substances